Compumedics Limited (ASX:CMP)

Australia flag Australia · Delayed Price · Currency is AUD
0.2750
+0.0050 (1.85%)
Jun 11, 2025, 3:40 PM AEST
-5.17%
Market Cap 52.81M
Revenue (ttm) 47.37M
Net Income (ttm) -1.59M
Shares Out 192.04M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE 27.50
Dividend n/a
Ex-Dividend Date n/a
Volume 9,309
Average Volume 20,051
Open 0.2750
Previous Close 0.2700
Day's Range 0.2750 - 0.2750
52-Week Range 0.2450 - 0.3650
Beta 0.52
RSI 45.53
Earnings Date May 29, 2025

About Compumedics

Compumedics Limited engages in the research, development, manufacture, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the United States, and Europe. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Okti; Grael PSG; Grael 4K PSG; Falcon PSG; Falcon HST; Somté, an investigative tool; Siesta 802; and Somté PSG. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's hom... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1987
Employees 155
Stock Exchange Australian Securities Exchange
Ticker Symbol CMP
Full Company Profile

Financial Performance

In 2024, Compumedics's revenue was 50.26 million, an increase of 17.10% compared to the previous year's 42.92 million. Losses were -338,000, -94.48% less than in 2023.

Financial Statements

News

There is no news available yet.